Euro
USD
British Pound
NULL
Product Description
JNJ-7706621 is a potent inhibitor of cyclin-dependent kinases (CDK) and Aurora kinases with IC₅₀ values of 9 nM, 4 nM, 11 nM and 15 nM for CDK1, 2 and Aurora A, B, respectively. In vitro assays shows that JNJ-7706621 inhibits glioblastoma cellular viability, proliferation, and migration via inducing glioblastoma cells apoptosis.
JNJ-7706621 is a potent inhibitor of cyclin-dependent kinases (CDK) and Aurora kinases with IC₅₀ values of 9 nM, 4 nM, 11 nM and 15 nM for CDK1, 2 and Aurora A, B, respectively. In vitro assays shows that JNJ-7706621 inhibits glioblastoma cellular viability, proliferation, and migration via inducing glioblastoma cells apoptosis.
Biovision | B1941 | JNJ-7706621 DataSheet
Alternate Name/Synonyms: 4-[[5-amino-1-(2,6-difluorobenzoyl)-1,2,4-triazol-3-yl]amino]benzenesulfonamide
Appearance: Crystalline solid
Formulation: N/A
CAS Number: 443797-96-4
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₁₅H₁₂F₂N₆O₃S
Molecular Weight: 394.36
Cell-Permeable?: Yes
Purity: ≥98% by HPLC
Solubilities: DMSO (>18 mg/ml)
Handling: Protect from air and light
Country of Origin: USA
Tag Line: A potent inhibitor of cyclin-dependent kinases (CDK) and Aurora kinases
MDL Number: N/A
PubChem CID: 5330790
SMILES: C1=CC(=C(C(=C1)F)C(=O)N2C(=NC(=N2)NC3=CC=C(C=C3)S(=O)(=O)N)N)F
InChi: InChI=1S/C15H12F2N6O3S/c16-10-2-1-3-11(17)12(10)13(24)23-14(18)21-15(22-23)20-8-4-6-9(7-5-8)27(19,25)26/h1-7H,(H2,19,25,26)(H3,18,20,21,22)
InChi Key: KDKUVYLMPJIGKA-UHFFFAOYSA-N
